According to a different study, female non‐small‐cell lung cancer (NSCLC) patients with the IGF2BP2 rs1470579 polymorphism showed a statistically significant difference in genotype distribution compared with controls. Here, IGF2BP2 is linked to non-small cell lung carcinoma.